Industry
Biotechnology
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
April 29, 2024 | 12:34 pm
Portfolio Pulse from Benzinga Newsdesk
April 19, 2024 | 11:47 am
Portfolio Pulse from Benzinga Insights
April 15, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
April 04, 2024 | 12:58 pm
Portfolio Pulse from Avi Kapoor
March 05, 2024 | 6:11 pm
Portfolio Pulse from Benzinga Newsdesk
March 05, 2024 | 3:36 pm
Portfolio Pulse from Benzinga Insights
February 16, 2024 | 1:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.